Jeil Pharma Holdings Inc (KRX:002620)
South Korea
· Delayed Price · Currency is KRW 8,450.00
-60.00 (-0.71%)
Last updated: Mar 10, 2026, 9:54 AM KST
Jeil Pharma Holdings Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 130,638 | 120,046 | 180,683 | 236,407 | 245,618 | 325,444 | Upgrade
|
| Market Cap Growth | 15.63% | -33.56% | -23.57% | -3.75% | -24.53% | 24.71% | Upgrade
|
| Enterprise Value | 370,467 | 328,142 | 429,021 | 424,544 | 404,795 | 543,483 | Upgrade
|
| Last Close Price | 8510.00 | 7753.08 | 11596.16 | 15107.77 | 15636.92 | 20637.06 | Upgrade
|
| PE Ratio | - | - | - | - | - | 28.47 | Upgrade
|
| PS Ratio | 0.18 | 0.15 | 0.23 | 0.30 | 0.32 | 0.43 | Upgrade
|
| PB Ratio | 0.28 | 0.27 | 0.45 | 0.56 | 0.49 | 0.65 | Upgrade
|
| P/TBV Ratio | 0.43 | 0.40 | 0.67 | 0.91 | 0.96 | 1.39 | Upgrade
|
| P/FCF Ratio | - | 593.17 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 226.33 | 26.43 | - | - | 18.33 | - | Upgrade
|
| EV/Sales Ratio | 0.52 | 0.42 | 0.53 | 0.54 | 0.53 | 0.71 | Upgrade
|
| EV/EBITDA Ratio | 7.15 | 112.46 | 12.82 | 126.46 | 48721.60 | 17.73 | Upgrade
|
| EV/EBIT Ratio | 9.97 | - | 20.51 | - | - | 24.70 | Upgrade
|
| EV/FCF Ratio | -51.60 | 1621.42 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.36 | 0.36 | 0.53 | 0.39 | 0.23 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | 3.23 | 53.19 | 6.40 | 48.44 | 13850.20 | 4.89 | Upgrade
|
| Debt / FCF Ratio | - | 766.93 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.20 | 0.18 | 0.39 | 0.26 | 0.14 | 0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.83 | 27.19 | 4.63 | 32.53 | 8166.30 | 3.91 | Upgrade
|
| Net Debt / FCF Ratio | -13.01 | 391.98 | -14.57 | -3.34 | -6.60 | -3.58 | Upgrade
|
| Asset Turnover | 0.81 | 0.88 | 0.92 | 0.90 | 0.86 | 0.88 | Upgrade
|
| Inventory Turnover | 3.72 | 4.61 | 4.94 | 5.38 | 4.88 | 5.17 | Upgrade
|
| Quick Ratio | 0.76 | 0.73 | 0.61 | 0.65 | 0.71 | 0.63 | Upgrade
|
| Current Ratio | 1.15 | 1.08 | 0.93 | 0.98 | 1.13 | 1.02 | Upgrade
|
| Return on Equity (ROE) | -2.38% | -15.82% | -3.22% | -18.07% | -2.57% | 3.05% | Upgrade
|
| Return on Assets (ROA) | 2.61% | -0.79% | 1.50% | -0.54% | -0.63% | 1.59% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.62% | -2.08% | 3.85% | -1.38% | -1.51% | 1.79% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.70% | -2.20% | 4.50% | -1.50% | -1.50% | 3.90% | Upgrade
|
| Earnings Yield | -22.51% | -42.62% | -8.99% | -31.54% | -1.42% | 3.51% | Upgrade
|
| FCF Yield | -5.50% | 0.17% | -5.89% | -13.84% | -4.19% | -10.29% | Upgrade
|
| Dividend Yield | 0.57% | 0.65% | 0.43% | 0.33% | 0.42% | 0.34% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 13.88% | Upgrade
|
| Buyback Yield / Dilution | 0.03% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 0.60% | 0.65% | 0.43% | 0.33% | 0.42% | 0.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.